Early research has suggested psilocybin, the active ingredient in magic mushrooms, may be effective at treating clinical depression and PTSD. Now, it is being studied as a potential new therapy ...

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study.

Sangamo's investigational gene therapy has been tied to an improvement in kidney health deterioration at 52 weeks for patients with Fabry disease.

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study.

What non-SSRI antidepressants or non-SSRI anxiety meds are out there? We’ll talk not only about alternatives to SSRIs but the alternatives to antidepressant medication in general.

Health New stem cell therapy shows 'promising' results for treating hair loss in preclinical trials Androgenetic alopecia treatment led to complete hair regrowth in some mice, research shows ...

Therapy For Perfectionists, Therapy Isn't Always About Becoming Better How a deep sense of incompleteness can drive perfectionists to therapy. Updated June 24, 2025 | Reviewed by Devon Frye ...

Four patients with infantile-onset Pompe’s disease received a single intravenous injection of an adeno-associated virus serotype 9 vector carrying codon-optimized complementary DNA encoding ...

Current approved CAR T-cell therapy treatments rely on an ex vivo route, in which a patient’s T cells are removed, genetically engineered to target antigens, and put back into the patient. From ...

FDA evaluating further regulatory actions after deaths Elevidys is the only gene therapy for Duchenne muscular dystrophy Sarepta suggested updating Elevidys' label June 24 (Reuters) - The U.S ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s Enflonsia.